SCR-LIP-000466 · Claim · machine-readable JSON →

In 20 women with lipedema versus 20 healthy controls, lipedema patients demonstrated clinically relevant pain and neuropathic pain features (VAS, LANSS, DN4), with LANSS correlating with VAS (ρ=0.529, p=0.017) and DN4 (ρ=0.521, p=0.018), but the study did not assess fibromyalgia or other chronic-pain comorbidities.

This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
low (GRADE)
Evidence
1 source(s)
Dates
2026-11-17 → 2026-11-17

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17

Evidence over time

2026Multidimensional Assessment of Pain and Related Factors In Lipedema: A Controlled Clinical Study. — Gümrük Aslan S, Barış Saklica Ş, Borman P. (2026) · contextual

Evidence (1)

Context (PECO)

Population20 women with clinically diagnosed lipedema and 20 healthy controls
Conditionlipedema
Exposurelipedema diagnosis and clinical stage
Comparatorage-matched healthy controls
Outcomepain intensity (VAS), neuropathic pain (LANSS, DN4), SF-12 quality of life
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log